| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/17/2011 | WO2011030864A1 Aniline compounds |
| 03/17/2011 | WO2011030163A1 Use of guaifenesin for inhibiting mucin secretion |
| 03/17/2011 | WO2011030116A1 Use of steroid compounds for inflammatory and autoimmune disorders |
| 03/17/2011 | WO2011029525A1 A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes |
| 03/17/2011 | WO2011029218A1 Use of montmorillonite in manufacture of medicaments |
| 03/17/2011 | WO2010131909A3 Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases |
| 03/17/2011 | US20110066251 Anti-angiogenic compositions and methods of use |
| 03/17/2011 | US20110065918 New phenylalanine derivatives |
| 03/17/2011 | US20110065778 RNA Interference Mediated Inhibition of Muscarinic Colinergic Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 03/17/2011 | US20110065764 5- phenyl-isoxazole-3-carboxamide derivatives as trpv1 modulators |
| 03/17/2011 | US20110065760 Compounds for the inhibition of rotamases and use thereof |
| 03/17/2011 | US20110065746 Composition of solifenacin or salt thereof for use in solid formulation |
| 03/17/2011 | US20110065738 Polycyclic guanine derivatives and use thereof |
| 03/17/2011 | US20110065734 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
| 03/17/2011 | US20110065720 Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases |
| 03/17/2011 | US20110065685 Novel indoles are cannabinoid receptor ligands |
| 03/17/2011 | US20110065679 Substituted Porphyrins |
| 03/17/2011 | US20110065678 Isoxazolidine derivatives |
| 03/17/2011 | US20110065673 Novel leukotriene receptor agonist |
| 03/17/2011 | US20110065187 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 03/17/2011 | US20110065186 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 03/17/2011 | US20110065180 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 03/17/2011 | US20110065138 Quantitative Method For Detecting Yessotoxins In Fishery Products On Based On The Activation That The Toxin Produces In Cellular Phosphodiesterases And Therapeutic Use Of This Activation |
| 03/17/2011 | US20110064811 Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 03/17/2011 | US20110064796 Concentrated, inhalable antibiotic formulation |
| 03/17/2011 | US20110064762 Protein a compositions and methods of use |
| 03/17/2011 | US20110064757 Nucleic acid molecules and polypeptides for immune modulation |
| 03/17/2011 | US20110064728 IL-17 Homologous Polypeptides and Therapeutic Uses Thereof |
| 03/17/2011 | US20110064725 High affinity, anti-human ige antibodies |
| 03/17/2011 | US20110061651 Formoterol superfine formulation |
| 03/17/2011 | US20110061649 Device and method for treating respiratory and other diseases |
| 03/17/2011 | CA2773998A1 Substituted carbonyl compound |
| 03/17/2011 | CA2773997A1 Aniline compound |
| 03/17/2011 | CA2773611A1 Use of guaifenesin for inhibiting mucin secretion |
| 03/17/2011 | CA2773600A1 Use of steroid compounds for inflammatory and autoimmune disorders |
| 03/17/2011 | CA2773490A1 A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes |
| 03/16/2011 | EP2295550A2 Crystal structures of GSK-3beta protein and protein complexes and their use. |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2295436A1 2-Phenyl-subsitituted Imidazotriazinones as Phosphodiesterase V inhibitors |
| 03/16/2011 | EP2295435A1 Substituted porphyrins and their therapeutic use |
| 03/16/2011 | EP2295434A2 Substituted 8-heteroaryl xanthines |
| 03/16/2011 | EP2295433A2 JNK inhibitors |
| 03/16/2011 | EP2295423A1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives |
| 03/16/2011 | EP2295413A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295412A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295409A1 Fluoro substituted cycloalkanoindoles and their use as prostaglandin D2 receptor antagonists |
| 03/16/2011 | EP2295404A2 Substituted tetracycline compounds |
| 03/16/2011 | EP2295079A2 Method for treating inflammation |
| 03/16/2011 | EP2295078A2 Method for treating inflammation |
| 03/16/2011 | EP2295067A1 E-selectin for inducing immunotolerance |
| 03/16/2011 | EP2295062A1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 03/16/2011 | EP2295060A2 Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/16/2011 | EP2295059A2 Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/16/2011 | EP2295055A2 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof |
| 03/16/2011 | EP2294917A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 03/16/2011 | EP2294077A1 Corticosteroid linked beta-agonist compounds for use in therapy |
| 03/16/2011 | EP2294050A2 Bis-aryl compounds for use as medicaments |
| 03/16/2011 | EP2293805A2 Lozenge composition for treating inflammatory diseases of the mouth and pharynx |
| 03/16/2011 | EP2293795A1 Pharmaceutical combination |
| 03/16/2011 | EP2293677A1 Nutritional composition for infants delivered via caesarean section |
| 03/16/2011 | EP2167470B1 Triazolo [1, 5-a]quinolines as adenosine a3 receptor ligands |
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 03/16/2011 | CN1994285B Sustained release micro-pellet of guaifenesin and preparation process thereof |
| 03/16/2011 | CN101985471A Folate-IgG conjugate as well as preparation method and application thereof |
| 03/16/2011 | CN101985457A Medicinal salts of cordycepin and preparation method and medicinal application thereof |
| 03/16/2011 | CN101985031A Traditional Chinese medicine composition for treating asthma |
| 03/16/2011 | CN101985024A Medicinal liquor having stomach harmonizing and channel activating effects |
| 03/16/2011 | CN101985020A Chinese medicament for treating tracheitis |
| 03/16/2011 | CN101985012A Chewable tablet forming process for improving stability and bioavailability of pharyngitis extract |
| 03/16/2011 | CN101985003A Medicinal liquor with effects of tonifying kidney and holding qi |
| 03/16/2011 | CN101984986A Medicament for treating swelling caused by long panting |
| 03/16/2011 | CN101984982A Medicament for treating rhinitis and preparation method thereof |
| 03/16/2011 | CN101984975A Medical composition containing cordycepin derivatives |
| 03/16/2011 | CN101984966A New medicinal composition |
| 03/16/2011 | CN101984957A Method for preparing valnemulin salt premix |
| 03/16/2011 | CN101491520B Local application medicine formulation |
| 03/16/2011 | CN101474373B Chinese medicine for treating acute pharyngitis |
| 03/16/2011 | CN101474155B Lung-targeted medicine carrying precursor liposome for injection and method of use thereof |
| 03/16/2011 | CN101416956B Ambroxol hydrochloride injection |
| 03/16/2011 | CN101209339B Wax candle with incense treating function and preparation method thereof |
| 03/16/2011 | CN101194944B Technique of preparing medicament for treating upper respiratory tract infection and quality control method |
| 03/16/2011 | CN101181563B Chrysoidine productive cough preparations as well as preparation method and mass control method |
| 03/16/2011 | CN101084951B Medicine for treating diseases concerned with respiratory and preparation method and application thereof |
| 03/16/2011 | CN101084898B Compound chemical medicine with antitussive and phlegm-eliminating action and its preparation technology |
| 03/16/2011 | CN101081212B Protease inhibitors liposomes aerosol |
| 03/16/2011 | CN101010067B Modafinil oral lyophilizate |
| 03/15/2011 | US7906650 Caspase inhibitors and uses thereof |
| 03/15/2011 | US7906644 2,4-pyrimidinediamine compounds and their uses |
| 03/15/2011 | US7906616 Truncated DANCE, DANCE complex and method of using these |
| 03/15/2011 | US7906141 Sustained-release, oral pharmaceutical forms of formulation |
| 03/15/2011 | US7906123 Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof |
| 03/15/2011 | CA2618511C Novel benzothiazolone derivatives |
| 03/15/2011 | CA2528385C A1 adenosine receptor antogonists |
| 03/15/2011 | CA2473910C Pyrimidine derivatives as rho-kinase inhibitors |
| 03/15/2011 | CA2468311C Benzothiazole derivatives |
| 03/15/2011 | CA2458266C Substituted urea retinoid agonists ii |
| 03/15/2011 | CA2431160C Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 03/15/2011 | CA2394809C Benzazole derivatives and their use as jnk modulators |
| 03/15/2011 | CA2379575C Pharmaceutically active sulfonamide derivatives |
| 03/10/2011 | WO2011029059A1 Use of aerosolized levofloxacin for treating cystic fibrosis |